Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Post by wanttoretireearlyon Mar 09, 2017 10:31am
91 Views
Post# 25956856

$0.50 per Common Share for a period of 2 years

$0.50 per Common Share for a period of 2 yearsI take this as a good news and it looks like it's stil open "announces that it intends to complete a non-brokered private placement"

Read more at https://www.stockhouse.com/news/press-releases/2017/03/09/ventripoint-announces-2-000-000-non-brokered-private-placement#LOtFfeKCd0mOdpLl.99

Some people should read the news more careful!

"Each Warrant will entitle the holder thereof to acquire one additional Common Share at a price of $0.50 per Common Share for a period of 2 years after the issuance of the Warrant."

This is good, a 50 cents when this stock was just 9 cents few days ago and it does not matter that it went to 92 cents, a 50 cents warrants at this time and for 2 years, GREAT!

This is what stock do, they go up they go down, you should trade and invest, GLTA.


Bullboard Posts